SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: manfredhasler who wrote (14622)9/16/2000 7:42:45 PM
From: Bluegreen  Read Replies (3) of 17367
 
Manfred you stated>>>>>>>>>>I do not want to go to much into this kind of discussion. I hope you can understand that ...<<<<<<<<
Manfred when you bash a HERO physician like Dr. Girior that is trying hard to get a miracle medication showing clinical benefit for severe amputations and outcome scores NOW all of a sudden you can't answer SIMPLE questions? Not to mention you describing some actions as pathetic?? And after that all of a sudden you don't want to get your hands dirty??? How can you help??? At least email major new organizations to FULLY investigate why Neuprex wasn't approved under Subpart E. Why relentlessly bash Dr. Girior??? At least he is trying to save kid's lives with Meningococcemia while you sit back and bash him when you haven't even taken the time to research the WHOLE history of the Phase III trial and what Subpart E guidelines entail. You have no idea of what role the FDA had in designing the trial. You have no idea of what constraints and parameters were put on him. So once again can we count on you to help get this miracle Biological to kids with Meningococcemia???? Won't take much of your time to send major news organizations an email. Your choice.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext